191 related articles for article (PubMed ID: 34718628)
1. Long-Term Effects of Metreleptin in Rabson-Mendenhall Syndrome on Glycemia, Growth, and Kidney Function.
Okawa MC; Cochran E; Lightbourne M; Brown RJ
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1032-e1046. PubMed ID: 34718628
[TBL] [Abstract][Full Text] [Related]
2. Metreleptin improves blood glucose in patients with insulin receptor mutations.
Brown RJ; Cochran E; Gorden P
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1749-56. PubMed ID: 23969187
[TBL] [Abstract][Full Text] [Related]
3. Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome.
Dos Santos SS; Ramaldes LA; Gabbay MAL; Moises RCS; Dib SA
Horm Res Paediatr; 2021; 94(7-8):313-316. PubMed ID: 34551418
[TBL] [Abstract][Full Text] [Related]
4. Two novel insulin receptor gene mutations in a patient with Rabson-Mendenhall syndrome: the first Korean case confirmed by biochemical, and molecular evidence.
Kim D; Cho SY; Yeau SH; Park SW; Sohn YB; Kwon MJ; Kim JY; Ki CS; Jin DK
J Korean Med Sci; 2012 May; 27(5):565-8. PubMed ID: 22563226
[TBL] [Abstract][Full Text] [Related]
5. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
[TBL] [Abstract][Full Text] [Related]
6. One Novel 2.43Kb Deletion and One Single Nucleotide Mutation of the
Chen X; Wang H; Wu B; Dong X; Liu B; Chen H; Lu Y; Zhou W; Yang L
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):183-187. PubMed ID: 29082893
[TBL] [Abstract][Full Text] [Related]
7. A Novel Mutation in the
Rojas Velazquez MN; Blanco F; Ayala-Lugo A; Franco L; Jolly V; Di Tore D; Martínez de Lapiscina I; Janner M; Flück CE; Pandey AV
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542117
[TBL] [Abstract][Full Text] [Related]
8. Management challenges of Rabson Mendenhall syndrome in a resource limited country: a case report.
Aftab S; Shaheen T; Asif R; Anjum MN; Saeed A; Manzoor J; Cheema HA
J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1429-1432. PubMed ID: 36106528
[TBL] [Abstract][Full Text] [Related]
9. A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney.
Abe Y; Sato T; Takagi M; Watanabe T; Nagayama Y; Hasegawa T; Abe T
J Pediatr Endocrinol Metab; 2012; 25(5-6):587-90. PubMed ID: 22876563
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans.
Pilitsi E; Peradze N; Perakakis N; Mantzoros CS
Metabolism; 2019 Aug; 97():32-39. PubMed ID: 31103608
[TBL] [Abstract][Full Text] [Related]
11. A Mutation in INSR in a Child Presenting with Severe Acanthosis Nigricans.
Tuhan H; Ceylaner S; Nalbantoğlu Ö; Acar S; Abacı A; Böber E; Demir K
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):371-374. PubMed ID: 28663160
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.
Zhou Q; Yu J; Yuan X; Wang C; Zhu Z; Zhang A; Gu W
Front Endocrinol (Lausanne); 2021; 12():606964. PubMed ID: 33995269
[TBL] [Abstract][Full Text] [Related]
13. Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism.
de Kerdanet M; Caron-Debarle M; Nivot S; Gaillot T; Lascols O; Fremont B; Bonaure M; Gie S; Massart C; Capeau J
Diabetes Metab; 2015 Sep; 41(4):331-337. PubMed ID: 25465274
[TBL] [Abstract][Full Text] [Related]
14. Insulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH-IGF-1 Axis.
Okawa MC; Tuska RM; Lightbourne M; Abel BS; Walter M; Dai Y; Cochran E; Brown RJ
J Clin Endocrinol Metab; 2023 Dec; 109(1):e96-e106. PubMed ID: 37595266
[TBL] [Abstract][Full Text] [Related]
15. Rabson-Mendenhall syndrome with recurrent cerebral infarcts caused by a novel INSR mutation.
Mohanan S; Chandrashekar L; Semple RK; Thappa DM; Parameswaran N; Negi VS; Ramassamy S
Int J Dermatol; 2013 Feb; 52(2):182-5. PubMed ID: 23347304
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome.
Weber DR; Stanescu DE; Semple R; Holland C; Magge SN
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1237-41. PubMed ID: 25153212
[TBL] [Abstract][Full Text] [Related]
17. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
Sienkiewicz E; Magkos F; Aronis KN; Brinkoetter M; Chamberland JP; Chou S; Arampatzi KM; Gao C; Koniaris A; Mantzoros CS
Metabolism; 2011 Sep; 60(9):1211-21. PubMed ID: 21741057
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of insulin receptor gene mutations contributing to Rabson-Mendenhall syndrome - phenotypic heterogeneity of insulin receptor gene mutations.
Jiang S; Fang Q; Zhang F; Wan H; Zhang R; Wang C; Bao Y; Zhang L; Ma X; Lu J; Gao F; Xiang K; Jia W
Endocr J; 2011; 58(11):931-40. PubMed ID: 21869538
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.
Kushchayeva YS; Kushchayev SV; Startzell M; Cochran E; Auh S; Dai Y; Lightbourne M; Skarulis M; Brown RJ
J Clin Endocrinol Metab; 2019 Jun; 104(6):2216-2228. PubMed ID: 30657911
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan.
Takeuchi T; Ishigaki Y; Hirota Y; Hasegawa Y; Yorifuji T; Kadowaki H; Akamizu T; Ogawa W; Katagiri H
J Diabetes Investig; 2020 May; 11(3):603-616. PubMed ID: 31677333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
